Skip to content
10-Q

Quarterly Report

Ambrx Biopharma Inc.

0000950170-23-040568

← back to feed
Filed
Aug 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 7, 2023 434.07M sh
Shares Diluted Q2 2023 · Jun 30, 2023 391.28M sh
Shares Diluted Q2 2023 · Jun 30, 2023 353.34M sh
Shares Diluted Q2 2023 · Jun 30, 2022 270.16M sh
Shares Diluted Q2 2023 · Jun 30, 2022 270.14M sh
Capex Q2 2023 · Jun 30, 2023 $783K
Capex Q2 2023 · Jun 30, 2022 $903K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$26.12M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$40.2M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $228.27M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $65.64M
Stockholders Equity Q2 2023 · Jun 30, 2023 $250.38M
Stockholders Equity Q2 2023 · Mar 31, 2023 $182.59M
Stockholders Equity Q2 2023 · Dec 31, 2022 $117.85M
Stockholders Equity Q2 2023 · Jun 30, 2022 $141.89M
Stockholders Equity Q2 2023 · Mar 31, 2022 $168.98M
Stockholders Equity Q2 2023 · Dec 31, 2021 $189.97M
Current Liabilities Q2 2023 · Jun 30, 2023 $18.18M
Current Liabilities Q2 2023 · Dec 31, 2022 $16.66M
Total Liabilities Q2 2023 · Jun 30, 2023 $29.56M
Total Liabilities Q2 2023 · Dec 31, 2022 $29.13M
Current Assets Q2 2023 · Jun 30, 2023 $241.41M
Current Assets Q2 2023 · Dec 31, 2022 $90.58M
Total Assets Q2 2023 · Jun 30, 2023 $279.94M
Total Assets Q2 2023 · Dec 31, 2022 $146.98M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.05
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.09
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.11
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.19
Eps Basic Q2 2023 · Jun 30, 2023 −$0.05
Eps Basic Q2 2023 · Jun 30, 2023 −$0.09
Eps Basic Q2 2023 · Jun 30, 2022 −$0.11
Eps Basic Q2 2023 · Jun 30, 2022 −$0.19
Sga Expense Q2 2023 · Jun 30, 2023 $5.9M
Sga Expense Q2 2023 · Jun 30, 2023 $12.21M
Sga Expense Q2 2023 · Jun 30, 2022 $4.82M
Sga Expense Q2 2023 · Jun 30, 2022 $9.39M
Rd Expense Q2 2023 · Jun 30, 2023 $14.39M
Rd Expense Q2 2023 · Jun 30, 2023 $24.14M
Rd Expense Q2 2023 · Jun 30, 2022 $18.06M
Rd Expense Q2 2023 · Jun 30, 2022 $32.77M
Net Income Q2 2023 · Jun 30, 2023 −$17.83M
Net Income Q2 2023 · Jun 30, 2023 −$33.13M
Net Income Q2 2023 · Jun 30, 2022 −$28.84M
Net Income Q2 2023 · Jun 30, 2022 −$51.49M
Operating Income Q2 2023 · Jun 30, 2023 −$19.17M
Operating Income Q2 2023 · Jun 30, 2023 −$35.2M
Operating Income Q2 2023 · Jun 30, 2022 −$28.78M
Operating Income Q2 2023 · Jun 30, 2022 −$48.91M
Revenue Q2 2023 · Jun 30, 2023 $1.12M
Revenue Q2 2023 · Jun 30, 2023 $1.15M
Revenue Q2 2023 · Jun 30, 2022 $1.3M
Revenue Q2 2023 · Jun 30, 2022 $2.91M